Clinical Trials Logo

Clinical Trial Summary

What is the risk of aortic vascular graft and endograft infection in patients with aortic vascular graft/endograft and bloodstream infection?


Clinical Trial Description

All patients with previous aortic vascular graft and endograft surgery between years 2010 and 2021 in four regions of south Sweden (Skåne, Halland, Kronoberg and Blekinge) will be included in the study. These patients will be evaluated for bloodstream infection (BSI) or not. For all patients with BSI, the risk of aortic vascular graft and endograft infection will be investigated. Aortic vascular graft and endograft infection will be determined by usage of the MAGIC-criteria. Risk factors for developing aortic vascular graft and endograft infection will be investigated, and if possible used to construct a risk score. This risk score could be used by clinicians to determine if bacteremic patients with aortic vascular grafts or endografts should be evaluated for aortic vascular graft and endograft infection. ;


Study Design


Related Conditions & MeSH terms


NCT number NCT05521035
Study type Observational
Source Lund University
Contact Oskar Ljungquist, M.D, PhD
Phone +46424061000
Email oskar.ljungquist@med.lu.se
Status Recruiting
Phase
Start date September 1, 2022
Completion date September 1, 2024